reglab/housing_qa huggingface dataset:
DC Code § 7-2871.03 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 28B - Youth Athletic Concussion Protection|§ 7-2871.03. Training program

(a) The Mayor shall establish, through rulemaking, a training program on: (1) The nature and risk of a concussion; (2) The criteria for the removal of an athlete from physical participation in an athletic activity and his or her return to it; and (3) The risks to an athlete of not reporting an injury and continuing to physically participate in the athletic activity. (b) The Mayor shall determine, through rulemaking, which individuals shall be required to complete the training program. (c) In addition to those individuals required to complete the training program, the Department of Health may make the program available to any interested individual, including school personnel, parents, students, and athletes.  (Oct. 20, 2011, D.C. Law 19-22, § 4, 58 DCR 6506.)
DC Code § 7-2871.04 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 28B - Youth Athletic Concussion Protection|§ 7-2871.04. Materials development and distribution

(a) The Department of Health shall create educational materials on the nature and risk of concussions. (b) Before an athlete may participate in an athletic activity, the organizing entity shall provide the educational materials developed pursuant to subsection (a) of this section to the athlete and the parent or guardian of the athlete. The athlete and the parent or guardian of the athlete shall sign a statement acknowledging receipt of the materials and return it to the organizing entity before the athlete shall be allowed to participate in the athletic activity.  (Oct. 20, 2011, D.C. Law 19-22, § 5, 58 DCR 6506.)
DC Code § 7-2871.05 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 28B - Youth Athletic Concussion Protection|§ 7-2871.05. Rules

(a)(1) Within 120 days of October 20, 2011, the Mayor, pursuant to subchapter I of Chapter 5 of Title 2 [§ 2-501 et seq.], shall issue rules to implement the provisions of this chapter. (b) The Mayor, through rulemaking, may expand the authority of this chapter to include athletic activities that are non-interscholastic school-sponsored or organized by a non-governmental organization.  (Oct. 20, 2011, D.C. Law 19-22, § 6, 58 DCR 6506.)
DC Code § 7-2901 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 29 - Health Care System Development Commission|§ 7-2901. Establishment; purpose

There is established a Health Care System Development Commission (“Commission”) to develop recommendations and an implementation plan for developing the health care system.  (Oct. 20, 1999, D.C. Law 13-38, § 1302, 46 DCR 6373.)  Emergency Legislation For temporary (90-day) addition of §§ 7-2901 to 7-2906, see §§ 1302 to 1307 of the Service Improvement and Fiscal Year 2000 Budget Support Emergency Act of 1999 (D.C. Act 13-110, July 28, 1999, 46 DCR 6320). Short Title Section 1301 of D.C. Law 13-38 provided: “This title may be cited as the ‘Health Care System Development Commission Establishment Act of 1999’.”
DC Code § 7-2902 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 29 - Health Care System Development Commission|§ 7-2902. Qualifications; membership; terms of office

(a) The Commission shall consist of 11 members as follows: (1) There shall be 3 ex-officio voting members as follows: (A) The Mayor of the District of Columbia (“Mayor”); (B) The Chairman of the Council of the District of Columbia (“Council”); and (C) The Chairman of the Council’s Committee on Human Services. (2) There shall be 5 members appointed by the Mayor and 3 members appointed by the Council by resolution. (A) Appointed members of the Commission shall be persons with proven expertise in health care delivery, finance, insurance, public health, integrated health care delivery systems, or strategic planning. (B) Appointed members of the Commission shall be residents of the District. (b) A vacancy on the Commission shall be filled in the same manner that the original appointment was made. (c) The Commission shall select a chair from among its ex-officio members. (d) Six members of the Commission shall constitute a quorum. (e) The term of members shall end 180 days after October 20, 1999.  (Oct. 20, 1999, D.C. Law 13-38, § 1303, 46 DCR 6373.)
DC Code § 7-2903 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 29 - Health Care System Development Commission|§ 7-2903. Compensation

Members of the Commission shall not receive compensation or reimbursement for actual expenses incurred in the performance of official duties.  (Oct. 20, 1999, D.C. Law 13-38, § 1304, 46 DCR 6373.)
DC Code § 7-2904 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 29 - Health Care System Development Commission|§ 7-2904. Duties

(a) The Commission shall establish criteria to be used in the development of recommendations. The criteria shall include, but not be limited to, the following: (1) Efficiency and effectiveness of the District’s health care system; (2) Access to quality health care services; (3) Consistency with financial plan and budget of the District; (4) Community impact; and (5) Economic benefits. (b) Within 120 days after its initial meeting, the Commission shall develop a set of recommendations for developing the health care system which addresses the following: (1) Inpatient bed over-capacity; (2) Distribution of health care services and providers; (3) The role and the needs of the District of Columbia Public Benefit Corporation; (4) Maintenance of safety net providers; (5) Impediments to accessing care beyond the lack of health care insurance; (6) Fiscal impact of expanding health insurance coverage, including a study of the utilization of available health maintenance organization coverage by the Medicaid eligible population for each year since the advent of Medicaid HMO coverage in the District of Columbia, and the number of medically indigent District residents who have been provided care at area hospitals as compared to the total number of medically indigent persons who have received care in each hospital in each of the past 3 years; (7) Implementation schedule for developing the health care system; and (8) Other issues. (c) The recommendations shall be developed in accordance with the criteria established in this section.  (Oct. 20, 1999, D.C. Law 13-38, § 1305, 46 DCR 6373.)
DC Code § 7-2905 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 29 - Health Care System Development Commission|§ 7-2905. Approval of recommendations

(a) The Mayor shall transmit the recommendations of the Commission to the Council for approval. (b) The recommendations shall be transmitted to the Council for a 45-day period, excluding days of Council recess. The Council shall take action to approve or disapprove the recommendations. If the Council does not take action within the 45-day period, the recommendations shall be deemed disapproved.  (Oct. 20, 1999, D.C. Law 13-38, § 1306, 46 DCR 6373.)  Resolutions Resolution 13-594, the “Health Care System Development Commission Recommendations Emergency Approval Resolution of 2000”, was approved effective June 26, 2000.
DC Code § 7-2906 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 29 - Health Care System Development Commission|§ 7-2906. Office space and staffing

(a) The Mayor shall provide sufficient office space, detail staff, and technical and administrative support to assist the Commission in the fulfillment of its duties. (b) The Commission shall have the authority to request directly from each department, agency, or instrumentality of the District government, and each department, agency, or instrumentality is hereby authorized to furnish directly to the Commission upon its request, any information deemed necessary by the Commission to carry out its functions under this subchapter.  (Oct. 20, 1999, D.C. Law 13-38, § 1307, 46 DCR 6373.)
DC Code § 7-3001 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3001. Legislative findings

(a) The current system of treating substance abusers in the District does not serve the needs of the community. There are between 65,000 and 100,000 persons in the District who need treatment for substance abuse. In the first 11 months of FY1999, the Addiction Prevention and Recovery Administration (“APRA”) served only 5,700 clients. No statistics are available regarding whether these individuals were successfully treated. Among other things, too few detoxification services slots create a bottleneck in its treatment programs. (b) The financial costs associated with substance abuse are enormous. According to some estimates, these costs probably exceed $1 billion in the District for health care expenditures, premature death, impaired productivity, motor vehicle crashes, crime, and social welfare cases due to alcohol and drug abuse. For every $1 spent on substance abuse treatment an average of $7 is saved in costs associated with criminal justice, health care and social services. (c) Even more critical are the tragic human costs associated with substance abuse. Substance abuse is a major factor in crime, domestic violence, child abuse, joblessness, emergency room visits, AIDS cases, and public health in the District. (d) In the District, the human costs are pervasive and devastating. Sixty-seven percent of recent offenders in the District tested positive in at least half of all drug tests. Similarly, 69% of APRA’s clients have an arrest record. Eighty-five percent of child protection cases, 75% of foster care cases, and 35% of AIDS cases are related to drug abuse. Moreover, one in 7 mothers delivering babies test positive for drug use as well; 38% of emergency room visit patients are under the influence of alcohol. Finally, up to 50% of perpetrators of domestic violence have substance abuse problems. (e) Access to meaningful treatment is clearly a major hurdle to recovery. Seventy-nine percent of APRA’s clients were unemployed and had no insurance. Importantly, while 19.2% of APRA’s clients are eligible for Medicaid, APRA does not access Medicaid dollars for outpatient and residential treatment services. This oversight results is the loss of millions of dollars for such services. (f) The existing programs offered by APRA are insufficient. Sixty percent of substance abusers have psychiatric disorders, but only a fraction of those receive treatment. The Latino community is underserved because of the lack of bilingual residential treatment programs. Additionally, existing services fail to meet the treatment needs of youth, the elderly, pregnant and parenting women, and persons with disabilities.  (July 18, 2000, D.C. Law 13-146, § 2, 47 DCR 4350; Apr. 24, 2007, D.C. Law 16-305, § 29(a), 53 DCR 6198.)  Effect of Amendments D.C. Law 16-305, in subsec. (f), substituted “persons with disabilities” for “the disabled”.
DC Code § 7-3003 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3003. Establishment of the Drug Treatment Choice Program; purpose

There is established the Drug Treatment Choice Program (“Program”). The purpose of the Program is to provide District residents with access to substance abuse rehabilitation and aftercare plans at the treatment provider of their choice in consultation with a qualified substance abuse counselor, and subject to the availability of funds in the Addiction Recovery Fund.  (July 18, 2000, D.C. Law 13-146, § 4, 47 DCR 4350.)  Section References This section is referenced in § 7-3003.01. Emergency Legislation For temporary (90 day) addition, see § 2(a) of Choice in Drug Treatment Emergency Amendment Act of 2008 (D.C. Act 17-280, January 29, 2008, 55 DCR 1534). Temporary Legislation Section 2(a) of D.C. Law 17-142 added a section to read as follows: “Sec. 4a. Establishment of the Access to Recovery Voucher Program. “(a) There is established the Access to Recovery Voucher Program (’ATR’), which shall be administered by APRA. The purpose of ATR shall be to provide District residents with access to culturally sensitive, substance abuse treatment and recovery support services for the duration of the 3-year federal Access to Recovery grant awarded to APRA and to serve as an addition and complement to the Choice in Drug Treatment Program, established by section 4. “(b) The duty of APRA to administer ATR shall include: “(1) Community outreach and education; “(2) Collaborating with federal and local agencies in regard to individuals returning to the community after being incarcerated who require substance abuse treatment or recovery support services; and “(3) Ensuring that ATR achieves the projected target of serving over 11,000 individuals.” Section 4(b) of D.C. Law 17-142 provided that the act shall expire after 225 days of its having taken effect.
DC Code § 7-3003.01 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3003.01. Establishment of the Access to Recovery Voucher program

(a) There is established the Access to Recovery Voucher Program (“ATR”), which shall be administered by APRA. The purpose of ATR shall be to provide District residents with access to culturally sensitive substance-abuse treatment and recovery-support services for the duration of the 3-year federal Access to Recovery grant awarded to APRA and to serve as an addition and complement to the Choice in Drug Treatment Program, established by § 7-3003. (b) The duty of APRA to administer ATR shall include: (1) Community outreach and education; (2) Collaborating with federal and local agencies in regard to individuals returning to the community after being incarcerated who require substance-abuse treatment or recovery-support services; and (3) Ensuring that ATR achieves the projected target of serving over 11,000 individuals.  (July 18, 2000, D.C. Law 13-146, § 4a; as added Aug. 16, 2008, D.C. Law 17-219, § 5002(a), 55 DCR 7598.)  Section References This section is referenced in § 7-3015. Short Title Short title: Section 5001 of D.C. Law 17-219 provided that subtitle A of title V of the act may be cited as the “Choice in Drug Treatment Amendment Act of 2008”.
DC Code § 7-3005 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3005. Administration of the Drug Treatment Choice Program and Addiction Recovery Fund

APRA shall administer the Program and Fund by: (1) Performing certification of treatment providers; (2) Creating standardized intake forms and procedures to be utilized by APRA and treatment providers; (3) Monitoring intake screening and assessments performed by qualified substance abuse counselors located within the APRA or the treatment providers; (4) Determining whether the applicant is eligible to participate in the Program following the intake screening and assessment; (5) Requiring the persons performing the intake screening and assessment, after determining eligibility, to share with the client the entire spectrum of treatment providers and to inform the client of his or her right to select the treatment provider of his or her choice in consultation with a qualified substance abuse counselor; (6) Reviewing rehabilitation and aftercare plans, including estimated costs, submitted by treatment providers; (7) Providing payment directly to treatment providers for services rendered at such times as established between APRA and the treatment provider; and (8) Monitoring the rehabilitation and aftercare plans and the quality of the services rendered by the treatment providers.  (July 18, 2000, D.C. Law 13-146, § 6, 47 DCR 4350.)  Emergency Legislation For temporary (90 day) addition, see § 2 of Choice in Drug Treatment Grants Emergency Act of 2005 (D.C. Act 16-149, July 26, 2005, 52 DCR 7191).
DC Code § 7-3005.01 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3005.01. Certification and participation by treatment providers

To improve access to substance abuse rehabilitation and aftercare for persons needing addiction treatment services, the Director of the Department of Health (“Director”) is authorized to exercise procurement authority to carry out the purposes of this chapter independent of the Office of Contracting and Procurement. The Director may enter into provider agreements or other agreements only with providers certified under Chapter 23 of Title 29 of the District of Columbia Municipal Regulations. It shall no longer be necessary for providers to be certified under Chapter 24 of Title 29 of the District of Columbia Municipal Regulations in order to be eligible to provide services under the Choice in Drug Treatment Program. The Director shall exercise this authority consistent with Chapter 3A of Title 2; except that § 2-352.01(a) shall not apply.  (July 18, 2000, D.C. Law 13-146, § 6a; as added Oct. 20, 2005, D.C. Law 16-33, § 5042, 52 DCR 7503; Sept. 26, 2012, D.C. Law 19-171, § 212, 59 DCR 6190.)  Effect of Amendments The 2012 amendment by D.C. Law 19-171 substituted “consistent with Chapter 3A of Title 2; except that § 2-352.01(a) shall not apply” for “consistent with Unit A of Chapter 3 of Title 2, except with regard to the powers and duties outlined in § 2-301.05(a), (b), (c), and (e).” Emergency Legislation For temporary (90 day) addition, see § 5042 of Fiscal Year 2006 Budget Support Emergency Act of 2005 (D.C. Act 16-168, July 26, 2005, 52 DCR 7667). Short Title Short title of subtitle E of title V of Law 16-33: Section 5041 of D.C. Law 16-33 provided that subtitle E of title V of the act may be cited as the Choice in Drug Treatment Amendment Act of 2005.
DC Code § 7-3006 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3006. Confidential records

All information furnished to APRA pursuant to this chapter shall remain confidential and may be disclosed only to medical personnel for purposes of diagnosis and treatment; except, that with the prior written consent of the client, the information may be disclosed for the purposes of and in accordance with Chapter 2B of this title [§ 7-241 et seq.].  (July 18, 2000, D.C. Law 13-146, § 7, 47 DCR 4350; Dec. 4, 2010, D.C. Law 18-273, § 208, 57 DCR 7171.)  Effect of Amendments D.C. Law 18-273 substituted “and treatment; except, that with the prior written consent of the client, the information may be disclosed for the purposes of and in accordance with Chapter 2B of this chapter” for “and treatment”. Emergency Legislation For temporary (90 day) amendment of section, see § 208 of Data-Sharing and Information Coordination Emergency Amendment Act of 2010 (D.C. Act 18-530, August 6, 2010, 57 DCR 8099). For temporary (90 day) amendment of section, see § 208 of Data-Sharing and Information Coordination Congressional Review Emergency Amendment Act of 2010 (D.C. Act 18-582, October 20, 2010, 57 DCR 10118).
DC Code § 7-3007 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3007. Residency and insurance requirements

In addition to other eligibility requirements established pursuant to this chapter, a prospective client shall be a District resident and not have insurance benefits available for substance abuse treatment. A client shall continue to be a resident while participating in the Program.  (July 18, 2000, D.C. Law 13-146, § 8, 47 DCR 4350.)
DC Code § 7-3008 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 30 - Choice in Drug Treatment|§ 7-3008. Benefits

(a) APRA shall formulate guidelines that give priority for enrollment in the Program to any eligible minor, pregnant woman, or the parent, guardian, or other person who has legal custody of a minor. (b)(1) A client with no dependent children shall receive a maximum of up to $20,000 per year, subject to the availability of funds in the Fund. A client with a dependent child shall receive a maximum of up to $40,000 per year, subject to the availability of funds in the Fund and the discretion of the Director of the Department of Health. (2) The Director of the Department of Health is authorized to increase the maximum amounts set forth in this subsection to adjust for inflation. (c) By waiver, approved by the Administrator of APRA, expenditures in excess of the maximum amounts stated in subsection (b) of this section may be authorized where good cause is shown. (d) Nothing in this chapter shall be construed to create an entitlement to substance abuse treatment during any fiscal year if no funds remain available to the District government under a District or federal appropriation that has been enacted for the specific purpose of providing substance abuse treatment services.  (July 18, 2000, D.C. Law 13-146, § 9, 47 DCR 4350; Aug. 16, 2008, D.C. Law 17-219, § 5031, 55 DCR 7598.)  Effect of Amendments D.C. Law 17-219 rewrote subsec. (b), which had read as follows: “(b) A client with no dependent children shall receive a maximum of up to $10,000 per year, subject to the availability of funds in the Fund. A client with a dependent child or children shall receive a maximum of up to $25,000 per year, subject to the availability of funds in the Fund.” Short Title Short title: Section 5030 of D.C. Law 17-219 provided that subtitle M of title V of the act may be cited as the “Choice in Drug Treatment Maximum Benefit Amendment Act of 2008”.